{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T03:10:05Z","timestamp":1748229005701,"version":"3.41.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Agence R\u00e9gionale de Sant\u00e9 de Guyane"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The final challenge for malaria elimination in many countries is to interrupt the circulation of <jats:italic>Plasmodium vivax<\/jats:italic>. Given the unique biology of this parasite, innovative approaches are imperative, with a focus on identifying asymptomatic carriers of dormant parasite forms. This article delineates the recent epidemiological patterns of <jats:italic>P. vivax<\/jats:italic> malaria within a highly mobile and hard-to-reach population in the Guiana Shield. It further proposes an assessment of the potential reservoir of asymptomatic carriers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This analysis was based on data from: (i) two cross-sectional surveys carried out at the French-Surinamese border in 2015 and 2019, including adults returning from gold\u00a0mining sites located in French Guiana (FG), [questionnaires and blood samples, tested for polymerase chain reaction (PCR) and <jats:italic>P. vivax<\/jats:italic> serological exposure markers (SEM) of recent infection]; (ii) epidemiological malaria surveillance system in Suriname, including cases imported from gold\u00a0mining sites located in western FG between 2014 and 2020. Factors associated with <jats:italic>P. vivax<\/jats:italic> seropositivity were analysed by multiple logistic regression. The probability of carrying <jats:italic>P. vivax<\/jats:italic> parasites (blood-stage or hypnozoite) was estimated by a classification drawn from PCR results, SEM and reported recent history of illness.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Surveillance data showed a decrease in malaria imported cases from French Guiana between beginning and end of the analysed period (236 in 2014 to 74 in 2020) and an increase in the proportion of cases associated with <jats:italic>P. vivax<\/jats:italic> (52.4% in 2014 to 100% in 2020). The PCR-prevalence of <jats:italic>P. vivax<\/jats:italic> in survey samples decreased from 11.4% in 2015 to 4.0% in 2019; <jats:italic>P. vivax<\/jats:italic> seropositivity decreased from 44.7% to 28.4%. <jats:italic>P. vivax<\/jats:italic> seropositivity was positively associated with male sex, age and number of years spent in gold mining, type of activity, and reported malaria history (episode within less than nine months <jats:italic>OR<\/jats:italic>\u2009=\u200910.73, 95% <jats:italic>CI<\/jats:italic>: 5.87\u201319.6, or history of repeated older episodes <jats:italic>OR<\/jats:italic>\u2009=\u20095.31, 95% <jats:italic>CI<\/jats:italic>: 3.13\u20139.01).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our analysis shows an epidemiological evolution typical of a scenario of decreasing malaria circulation. Nevertheless, in 2020, gold miners in western FG still showed a moderate level of <jats:italic>P. vivax<\/jats:italic> circulation. Biological methods and epidemiological criteria can help to select potential parasite carriers, who could benefit from targeted drug administration.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s40249-025-01306-8","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T02:52:59Z","timestamp":1748227979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Plasmodium vivax transmission and asymptomatic carriage risk among artisanal gold\u00a0miners in western French Guiana, 2014\u20132020"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2426-2315","authenticated-orcid":false,"given":"Alice","family":"Sanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Pelleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise","family":"Musset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yassamine","family":"Lazrek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Hureau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedley","family":"Cairo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Vreden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maylis","family":"Douine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"1306_CR1","unstructured":"WHO. World malaria report 2023. World Health Organization, Geneva. 2023. https:\/\/www.who.int\/publications-detail-redirect\/9789240086173. Accessed 21 Dec 2023."},{"key":"1306_CR2","unstructured":"WHO Global Malaria Programme. Global technical strategy for malaria, 2016\u20132030, update 2021. World Health Organization, Geneva. 2021. https:\/\/www.who.int\/publications-detail-redirect\/9789240031357. Accessed 21 Dec 2023."},{"issue":"1","key":"1306_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12936-017-1925-6","volume":"16","author":"J Recht","year":"2017","unstructured":"Recht J, Siqueira AM, Monteiro WM, Herrera SM, Herrera S, Lacerda MVG. Malaria in Brazil, Colombia, Peru and Venezuela: current challenges in malaria control and elimination. Malar J. 2017;16(1):273.","journal-title":"Malar J"},{"key":"1306_CR4","unstructured":"World Health Organization. Control and elimination of plasmodium vivax malaria: a technical brief. World Health Organization, Geneva. 2015. http:\/\/apps.who.int\/iris\/bitstream\/10665\/181162\/1\/9789241509244_eng.pdf?ua=1&ua=1. Accessed 21 Dec 2023."},{"issue":"13","key":"1306_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/1475-2875-13-307","volume":"9","author":"C Smith","year":"2014","unstructured":"Smith C, Whittaker M. Beyond mobile populations: a critical review of the literature on malaria and population mobility and suggestions for future directions. Malar J. 2014;9(13):307.","journal-title":"Malar J"},{"issue":"9","key":"1306_CR6","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025585","volume":"7","author":"JH Adams","year":"2017","unstructured":"Adams JH, Mueller I. The biology of Plasmodium vivax. Cold Spring Harb Perspect Med. 2017;7(9): a025585.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"1306_CR7","doi-asserted-by":"publisher","first-page":"e1003561","DOI":"10.1371\/journal.pmed.1003561","volume":"18","author":"CS Chu","year":"2021","unstructured":"Chu CS, White NJ. The prevention and treatment of Plasmodium vivax malaria. PLOS Med. 2021;18(4):e1003561.","journal-title":"PLOS Med"},{"issue":"1","key":"1306_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12936-017-1784-1","volume":"16","author":"K Thriemer","year":"2017","unstructured":"Thriemer K, Ley B, Bobogare A, Dysoley L, Alam MS, Pasaribu AP, et al. Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group. Malar J. 2017;16(1):141.","journal-title":"Malar J"},{"issue":"12","key":"1306_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12916-014-0150-1","volume":"9","author":"JC Cutts","year":"2014","unstructured":"Cutts JC, Powell R, Agius PA, Beeson JG, Simpson JA, Fowkes FJI. Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis. BMC Med. 2014;9(12):150.","journal-title":"BMC Med"},{"issue":"6","key":"1306_CR10","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3390\/pathogens12060791","volume":"12","author":"L Kartal","year":"2023","unstructured":"Kartal L, Mueller I, Longley RJ. Using serological markers for the surveillance of Plasmodium vivax malaria: a scoping review. Pathog Basel Switz. 2023;12(6):791.","journal-title":"Pathog Basel Switz"},{"issue":"5","key":"1306_CR11","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41591-020-0841-4","volume":"26","author":"RJ Longley","year":"2020","unstructured":"Longley RJ, White MT, Takashima E, Brewster J, Morita M, Harbers M, et al. Development and validation of serological markers for detecting recent Plasmodium vivax infection. Nat Med. 2020;26(5):741\u20139.","journal-title":"Nat Med"},{"issue":"2","key":"1306_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009165","volume":"15","author":"J Rosado","year":"2021","unstructured":"Rosado J, White MT, Longley RJ, Lacerda M, Monteiro W, Brewster J, et al. Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contexts. PLoS Negl Trop Dis. 2021;15(2): e0009165.","journal-title":"PLoS Negl Trop Dis"},{"key":"1306_CR13","unstructured":"Global Malaria Programme, WHO. WHO guidelines for malaria. https:\/\/app.magicapp.org\/#\/guideline\/LwRMXj. Accessed 25 Aug 2024."},{"issue":"1","key":"1306_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4269\/ajtmh.14-0254","volume":"93","author":"G Newby","year":"2015","unstructured":"Newby G, Hwang J, Koita K, Chen I, Greenwood B, von Seidlein L, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015;93(1):125\u201334.","journal-title":"Am J Trop Med Hyg"},{"key":"1306_CR15","doi-asserted-by":"publisher","first-page":"e51773","DOI":"10.7554\/eLife.51773","volume":"9","author":"B Gao","year":"2020","unstructured":"Gao B, Saralamba S, Lubell Y, White LJ, Dondorp AM, Aguas R. Determinants of MDA impact and designing MDAs towards malaria elimination. Elife. 2020;9:e51773.","journal-title":"Elife"},{"key":"1306_CR16","first-page":"100511","volume":"22","author":"N Nekkab","year":"2023","unstructured":"Nekkab N, Obadia T, Monteiro WM, Lacerda MVG, White M, Mueller I. Accelerating towards P. vivax elimination with a novel serological test-and-treat strategy: a modelling case study in Brazil. Lancet Reg Health Am. 2023;22:100511.","journal-title":"Lancet Reg Health Am."},{"issue":"4_Suppl","key":"1306_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4269\/ajtmh.22-0754","volume":"110","author":"M Tusell","year":"2024","unstructured":"Tusell M, Coma-Cros EM, Bhamani B, Mithi V, Serra-Casas E, Williams NA, et al. Targeted drug administration to reduce malaria transmission: a systematic review and meta-analysis. Am J Trop Med Hyg. 2024;110(4_Suppl):65\u201372.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"1306_CR18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3201\/eid2202.151292","volume":"22","author":"V Pommier de Santi","year":"2016","unstructured":"Pommier de Santi V, Dia A, Adde A, Hyvert G, Galant J, Mazevet M, et al. Malaria in French Guiana Linked to Illegal Gold Mining. Emerg Infect Dis. 2016;22(2):344\u20136.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"1306_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s40475-020-00202-5","volume":"7","author":"M Douine","year":"2020","unstructured":"Douine M, Lambert Y, Musset L, Hiwat H, Blume LR, Marchesini P, et al. Malaria in gold miners in the Guianas and the Amazon: current knowledge and challenges. Curr Trop Med Rep. 2020;7(2):37\u201347.","journal-title":"Curr Trop Med Rep"},{"issue":"1","key":"1306_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12936-016-1367-6","volume":"15","author":"M Douine","year":"2016","unstructured":"Douine M, Musset L, Corlin F, Pelleau S, Pasquier J, Mutricy L, et al. Prevalence of Plasmodium spp. in illegal gold miners in French Guiana in 2015: a hidden but critical malaria reservoir. Malar J. 2016;15(1):315.","journal-title":"Malar J"},{"key":"1306_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.18352\/erlacs.9600","volume":"87","author":"M de Theije","year":"2009","unstructured":"de Theije M, Heemskerk M. Moving frontiers in the amazon: brazilian small-scale gold miners in suriname. Eur Rev Lat Am Caribb Stud Rev Eur Estud Latinoam Caribe. 2009;87:5\u201325.","journal-title":"Eur Rev Lat Am Caribb Stud Rev Eur Estud Latinoam Caribe"},{"key":"1306_CR22","unstructured":"Heemskerk M, Jacobs E, Pratley P. Mobile Migrant Population Study Suriname\u2014Assessment of mobile migrant population size, demographics, turnover, movement, and priority health needs [Internet]. Amsterdam, The Netherlands: Royal Tropical Institute, Amsterdam, The Netherlands. 2021. https:\/\/www.kit.nl\/institute\/publication\/mobile-migrant-population-study-suriname\/. Accessed 27 May 2024."},{"key":"1306_CR23","unstructured":"Le Tourneau FM. Chercheurs d\u2019or\u2014L\u2019orpaillage clandestin en Guyane fran\u00e7aise. CNRS Editions. 2020. (In French)."},{"key":"1306_CR24","volume":"4","author":"M Douine","year":"2021","unstructured":"Douine M, Lambert Y, Galindo MS, Mutricy L, Sanna A, Peterka C, et al. Self-diagnosis and self-treatment of malaria in hard-to-reach and mobile populations of the Amazon: results of Malakit, an international multicentric intervention research project. Lancet Reg Health Am. 2021;4: 100047.","journal-title":"Lancet Reg Health Am"},{"issue":"1","key":"1306_CR25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12936-018-2306-5","volume":"17","author":"M Douine","year":"2018","unstructured":"Douine M, Sanna A, Galindo M, Musset L, Pommier de Santi V, Marchesini P, et al. Malakit: an innovative pilot project to self-diagnose and self-treat malaria among illegal gold miners in the Guiana Shield. Malar J. 2018;17(1):158\u2013158.","journal-title":"Malar J"},{"key":"1306_CR26","doi-asserted-by":"crossref","unstructured":"Sanna A, Lambert Y, Jimeno Maroto I, Galindo M, Plessis L, Bardon T, et al. CUREMA project: a further step towards malaria elimination among hard-to-reach and mobile populations. 2024.","DOI":"10.21203\/rs.3.rs-4095394\/v1"},{"key":"1306_CR27","first-page":"189","volume":"72","author":"G Snounou","year":"2002","unstructured":"Snounou G, Singh B. Nested PCR analysis of Plasmodium parasites. Methods Mol Med. 2002;72:189\u2013203.","journal-title":"Methods Mol Med"},{"issue":"1","key":"1306_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1475-2875-11-10","volume":"11","author":"H Hiwat","year":"2012","unstructured":"Hiwat H, Hardjopawiro LS, Takken W, Villegas L. Novel strategies lead to pre-elimination of malaria in previously high-risk areas in Suriname, South America. Malar J. 2012;11(1):10.","journal-title":"Malar J"},{"issue":"1","key":"1306_CR29","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s12936-018-2570-4","volume":"17","author":"H Hiwat","year":"2018","unstructured":"Hiwat H, Mart\u00ednez-L\u00f3pez B, Cairo H, Hardjopawiro L, Boerleider A, Duarte EC, et al. Malaria epidemiology in Suriname from 2000 to 2016: trends, opportunities and challenges for elimination. Malar J. 2018;17(1):418.","journal-title":"Malar J"},{"key":"1306_CR30","doi-asserted-by":"publisher","unstructured":"Lambert Y, M\u00e9tras R, Sanna A, Galindo M, Hiwat H, Marchesini P, et al. Modeling the impact of Malakit intervention: one more step towards malaria elimination in the Guiana Shield? medRxiv. 2023. p. 2023.07.11.23292527. https:\/\/doi.org\/10.1101\/2023.07.11.23292527v1.","DOI":"10.1101\/2023.07.11.23292527v1"},{"key":"1306_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2019.01.022","volume":"197","author":"F Pizzitutti","year":"2019","unstructured":"Pizzitutti F, Mena CF, Feingold B, Pan WK. Modeling asymptomatic infections and work-related human circulation as drivers of unstable malaria transmission in low-prevalence areas: a study in the Northern Peruvian Amazon. Acta Trop. 2019;197: 104909.","journal-title":"Acta Trop"},{"issue":"2","key":"1306_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4269\/ajtmh.16-0030","volume":"96","author":"JF Sanchez","year":"2017","unstructured":"Sanchez JF, Carnero AM, Rosales LA, Baldeviano GC, Asencios JL, Edgel KA, et al. Unstable malaria transmission in the southern peruvian amazon and its association with Gold Mining, Madre de Dios, 2001\u20132012. Am J Trop Med Hyg. 2017;96(2):304\u201311.","journal-title":"Am J Trop Med Hyg"},{"issue":"20","key":"1306_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12936-021-03614-4","volume":"12","author":"R Lana","year":"2021","unstructured":"Lana R, Nekkab N, Siqueira AM, Peterka C, Marchesini P, Lacerda M, et al. The top 1%: quantifying the unequal distribution of malaria in Brazil. Malar J. 2021;12(20):87.","journal-title":"Malar J"},{"key":"1306_CR34","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1139\/facets-2016-0063","volume":"2","author":"LM Freitas de Souza","year":"2017","unstructured":"Freitas de Souza LM. Experiential knowledge, suffering, and vicissitudes of having malaria in the Brazilian Amazon: an ethnographic study. FACETS. 2017;2:410\u201328.","journal-title":"FACETS"}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-025-01306-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40249-025-01306-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-025-01306-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T02:53:04Z","timestamp":1748227984000},"score":1,"resource":{"primary":{"URL":"https:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-025-01306-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1306"],"URL":"https:\/\/doi.org\/10.1186\/s40249-025-01306-8","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Each participant to cross-sectional surveys gave written consent after clear and appropriate information. Ethics approvals were obtained from the national ethical committee in Suriname, the \u201cCommissie voor Mensgebonden Wetenschappelijk Onderzoek\u201d: opinions Number VG10-14 and Number DVG-738).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MW is an inventor on patent PCT\/US17\/67926 on a system, method, apparatus and diagnostic test for P. vivax; none of the other authors declare any competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}